Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Glenmark Pharmaceuticals Ltd on Thursday reported a consolidated profit after tax of Rs 354.49 crore in the second quarter ...